Evidence map›Paper›PMID 38451290›Full record

ArticleHuman genetics2024

Heterozygous MAP3K20 variants cause ectodermal dysplasia, craniosynostosis, sensorineural hearing loss, and limb anomalies.

Daniel Brooks, Elizabeth Burke, Sukyeong Lee, Tanya N Eble, Melanie O'Leary, Ikeoluwa Osei-Owusu, Heidi L Rehm, Shweta U Dhar, Lisa Emrick, David Bick and 13 more

Open access · greenAbstract readCase Reports
In one paragraph

Article in Human genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 6 institutions in 2 countries.

Daniel Brooks *Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
Elizabeth Burke *NIH Undiagnosed Diseases Program, Common Fund, Office of the Director, NIH and National Human Genome Research Institute, NIH, Bethesda, MD, USA.
Sukyeong LeeVerna and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, TX, USA.ORCID http://orcid.org/0000-0001-6054-6628
Tanya N EbleDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
Melanie O'LearyProgram in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-8718-4759
Ikeoluwa Osei-OwusuProgram in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-1429-3532
Heidi L RehmProgram in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-6025-0015
Shweta U DharDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.ORCID http://orcid.org/0000-0003-0416-083X
Lisa EmrickDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
David BickHudson Alpha Institute for Biotechnology, Huntsville, AL, USA.ORCID http://orcid.org/0000-0002-8750-306X
Michelle NehrebeckyNIH Undiagnosed Diseases Program, Common Fund, Office of the Director, NIH and National Human Genome Research Institute, NIH, Bethesda, MD, USA.
Ellen MacnamaraNIH Undiagnosed Diseases Program, Common Fund, Office of the Director, NIH and National Human Genome Research Institute, NIH, Bethesda, MD, USA.
Dídac Casas-AlbaDepartment of Genetic Medicine, Pediatric Institute of Rare Diseases (IPER), CIBER on Rare Diseases (CIBERER), Hospital Sant Joan de DéuEsplugues de Llobregat, 08950, Barcelona, Spain.ORCID http://orcid.org/0000-0001-5659-9188
Judith ArmstrongDepartment of Genetic Medicine, Pediatric Institute of Rare Diseases (IPER), CIBER on Rare Diseases (CIBERER), Hospital Sant Joan de DéuEsplugues de Llobregat, 08950, Barcelona, Spain.ORCID http://orcid.org/0000-0003-0588-9307
Carolina PratDepartment of Dermatology, Hospital Sant Joan de Deu, Esplugues de Llobregat, 08950, Barcelona, Spain.ORCID http://orcid.org/0000-0002-2570-4907
Antonio F Martínez-MonsenyDepartment of Genetic Medicine, Pediatric Institute of Rare Diseases (IPER), CIBER on Rare Diseases (CIBERER), Hospital Sant Joan de DéuEsplugues de Llobregat, 08950, Barcelona, Spain.ORCID http://orcid.org/0000-0002-0960-3153
Francesc PalauDepartment of Genetic Medicine, Pediatric Institute of Rare Diseases (IPER), CIBER on Rare Diseases (CIBERER), Hospital Sant Joan de DéuEsplugues de Llobregat, 08950, Barcelona, Spain.ORCID http://orcid.org/0000-0002-8635-5421
Pengfei LiuDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.ORCID http://orcid.org/0000-0002-4177-709X
David AdamsNIH Undiagnosed Diseases Program, Common Fund, Office of the Director, NIH and National Human Genome Research Institute, NIH, Bethesda, MD, USA.
Undiagnosed Diseases Network
Seema LalaniDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
Jill A Rosenfeld *Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA. mokry@bcm.edu.ORCID http://orcid.org/0000-0001-5664-7987
Lindsay C Burrage *Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA. burrage@bcm.edu.ORCID http://orcid.org/0000-0002-5108-8861
Baylor College of Medicine · USCentre for Biomedical Network Research on Rare Diseases · ESNational Human Genome Research Institute · USBroad Institute · USHospital Sant Joan de Déu Barcelona · ESHudsonAlpha Institute for Biotechnology · US

Funding

Resource and Service SectionU54OD030165 · OD · BAYLOR COLLEGE OF MEDICINE · PI MATTHEW E ROTH · 2020 to 2026
$16.6M
Joint Center for Mendelian GenomicsUM1HG008900 · NHGRI · BROAD INSTITUTE, INC. · PI O'DONNELL-LURIA, ANNE, REHM, HEIDI L · 2016 to 2020
$16.5M
Broad Institute Mendelian Genomic Research CenterU01HG011755 · NHGRI · BROAD INSTITUTE, INC. · PI Anne O'Donnell-Luria, MICHAEL E TALKOWSKI · 2021 to 2026
$14.6M
Pilot of New Technologies to Increase the Genomic Diagnosis of Undiagnosed Disease Network (UDN) PatientsU01HG007709 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI BACINO, CARLOS A., LEE, BRENDAN · 2014 to 2022
$14.3M
Clinical Genome Wide Sequencing Core for the Undiagnosed Disease NetworkU01HG007943 · NHGRI · MEDICAL COLLEGE OF WISCONSIN · PI WORTHEY, ELIZABETH A · 2014 to 2017
$4.1M
A powerful web-based discovery platform for rare disease geneticsR01HG009141 · NHGRI · BROAD INSTITUTE, INC. · PI QUINLAN, AARON R, REHM, HEIDI L · 2017 to 2020
$2.9M
Structure, Function, and Mechanism of a Mitochondrial ChaperoneR01GM142143 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI TSAI, FRANCIS T.F. · 2021 to 2024
$2.2M
Protein Crystallization ImagerS10OD030246 · OD · BAYLOR COLLEGE OF MEDICINE · PI LEE, SUKYEONG · 2021 to 2021
$136k
NHGRI NIH HHS R01 HG009141NHGRI NIH HHS U01 HG007709NHGRI NIH HHS U01 HG007943NHGRI NIH HHS U01 HG011755NHGRI NIH HHS UM1 HG008900NHGRI NIH HHS UM1HG008900NIGMS NIH HHS R01 GM142143NIH HHS S10 OD030246NIH HHS S10-OD030246NIH HHS U01HG007709NIH HHS U01HG007943NIH HHS U54 OD030165
6 · The paper itself

Abstract

Biallelic pathogenic variants in MAP3K20, which encodes a mitogen-activated protein kinase, are a rare cause of split-hand foot malformation (SHFM), hearing loss, and nail abnormalities or congenital myopathy. However, heterozygous variants in this gene have not been definitively associated with a phenotype. Here, we describe the phenotypic spectrum associated with heterozygous de novo variants in the linker region between the kinase domain and leucine zipper domain of MAP3K20. We report five individuals with diverse clinical features, including craniosynostosis, limb anomalies, sensorineural hearing loss, and ectodermal dysplasia-like phenotypes who have heterozygous de novo variants in this specific region of the gene. These individuals exhibit both shared and unique clinical manifestations, highlighting the complexity and variability of the disorder. We propose that the involvement of MAP3K20 in endothelial-mesenchymal transition provides a plausible etiology of these features. Together, these findings characterize a disorder that both expands the phenotypic spectrum associated with MAP3K20 and highlights the need for further studies on its role in early human development.

Indexed as

CraniosynostosesEctodermal DysplasiaHearing Loss, SensorineuralHeterozygoteChildChild, PreschoolFemaleHumansInfantLimb Deformities, CongenitalMaleMAP Kinase Kinase KinasesMutationPhenotypeMAP Kinase Kinase Kinases

Identifiers

PMID38451290
PMCPMC11191325
OpenAlexW4392560029

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.